Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of primaquine dosing strategies for vivax malaria in patients with G6PD deficiency
RBR-2rcm2gPhase 2Recruiting
- Sponsor
- Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of primaquine and chloroquine in malaria (4 arms), sponsored by Fundação de Medicina Tropical Dr. Heitor Vieira Dourado. Primary endpoint: Safety of primaquine regimens. Started Jul 2018; status: recruiting.
02
Drugs
primaquinechloroquine
03
Conditions
malaria
Beyond the preview
Go deeper on RBR-2rcm2g.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2rcm2g.